Health And Pharmaceutical - News from Health and Pharma Industry

Centre to set up AIIMS-like institution in WB

The Centre would set up an AIIMS-like institution in West Bengal as part of the second phase of the Pradhan Mantri Swasthya Suraksha Yojana.

Two pharma cos ready for trials of H1N1 vaccine

Two pharmaceutical companies have sought permission from the Indian Council of Medical Research to start clinical trials for swine flu vaccine prepared by them using a new method.

Ranbaxy recalls drugs for skin disease from US

Ranbaxy Laboratories has recalled from the US market cartons of Sotret Isotretinoin capsules.

Wockhardt gets FDA approval for Nicardipine injections

Wockhardt said it has received the final approval from the US FDA for marketing Nicardipine HCI injections.

Zenotech Labs June Q net loss widens to Rs 3.41 cr

Drug maker Zenotech Laboratories reported Rs 3.41 crore loss for the quarter ended June 30, against a net loss of Rs 2.66 crore in the same period previous fiscal.

Glenmark settles patent dispute with Medicis

Pharma firm Glenmark said it has settled all pending patent disputes with US-based Medicis.

Fortis, Apollo eye medical tourism mkt in Mauritius

Within a span of six months, as the world was mourning the global recession, two of India’s largest hospital chains, Prathap Reddy promoted Apollo Hospitals and Malvinder and Shivinder Singh promoted Fortis Healthcare have ventured out to Mauritius.

Cipla unveils drug to combat H1N1 virus

Mumbai-based Cipla has launched Oseltamivir, a generic version of Roche’s Tamiflu, used in the treatment of the H1N1 virus, under the brand name, Antiflu, in India.

Cipla launches drug to treat Swine flu virus

Cipla Ltd has announced the launch of Antiflu to treat H1N1 swine flu virus.

GSM to donate 50 mn doses of swine flu vaccine to WHO

WHO has said GlaxoSmithKline is to donate 50 million doses of pandemic H1N1 vaccine to the WHO.

Dr Reddy's files for marketing Lipitor generic

Dr Reddy's Laboratories has filed for marketing a generic version of Pfizer's cholesterol-lowering drug Lipitor in the US, the company said on Saturday.

Amatrra Spa, pursuing holistic health solutions

Marking five years of impeccable service-, Amatrra Spa continues to provide holistic health & wellness solutions as India’s premiere lifestyle day spa.

Wockhardt Sep qtr net loss at Rs 54.20 cr

Pharmaceutical firm Wockhardt reported a consolidated net loss of Rs 54.20 crore for the quarter ended September 30.

GlaxoSmithKline Pharmaceuticals net sales up 12% in third quarter of FY 2009

GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the third quarter ended 30th September 2009.

GSK Pharma Q3 profit rises 7%

GSK reported a rise of 7 per cent in net profit to Rs 141.08 crore.

Tata Chemicals Q2 net profit at Rs 222.83 cr

Tata Chemicals reported a consolidated net profit of Rs 222.83 crore for Q2.

Sun Pharma’s net dips 11% on US sales

Mumbai-based Sun Pharmaceuticals Industries Ltd has reported a 11% decline in its net profit for the second quarter ending September 30, 2009, on the back of lower sales revenue from the US market.

Fortis Healthcare Q2 net up by 23%

Driven by robust growth in its larger units, hospital chain Fortis Healthcare reported a 23.4 per cent increase in net profit.

Dabur Q2 net up 30.7%

Dabur India reported a 30.7% jump in consolidated net profit during second quarter.

India needs more provisions for basic health care: Amartya

India needs to invest more in providing basic health care services, especially in rural areas and backward states, noted economist and Nobel laureate Amartya Sen said in Mumbai.

Dr Reddy's Q2 net up 3 fold at Rs 240 cr

Pharma firm Dr Reddy's reported a near three-fold jump in its consolidated net profit at Rs 239.85 crore for the second quarter ended September 30, 2009.

Latest News

Print Edition

Events